期刊文献+

4'-去甲基表鬼臼毒素的酶法糖基化 被引量:1

Enzymatic glycosylation of 4'-demethylepipodophyllotoxin
原文传递
导出
摘要 4'-去甲基表鬼臼毒素(4'-demethylepipodophyllotoxin,DMEP)的糖苷衍生物具有多种药理活性,但其化学合成面临位置及立体选择性和基团的保护与脱保护等诸多挑战。该研究从库拉索芦荟Aloe barbadensis中克隆得到1个新颖糖基转移酶(glycosyltransferase,GT)基因Ab GT5,并成功进行了外源表达及蛋白纯化。重组Ab GT5能够催化4'-去甲基表鬼臼毒素进行糖基化,获得的产物经MS,~1H-NMR,^(13)C-NMR,HSQC以及HMBC等波谱技术鉴定为4'-去甲基表鬼臼毒素-4'-O-β-D-葡萄糖苷。酶学性质研究发现AbGT5的最适反应温度为20℃,最适pH 9.0,且不依赖金属离子。在最适反应条件下,4'-去甲基表鬼臼毒素的转化率可达80%。该研究表明利用新颖糖基转移酶AbGT5可实现4'-去甲基表鬼臼毒素的高效酶法糖基化,为其糖基化提供新方法。 The glycosides of 4'-demethylepipodophyllotoxin (DMEP) possess various pharmacological activities; however, the chemical synthesis of these glycosides faces challenges in regioselectivity, stereoselectivity, and the protection and de-protection of functional groups. In this work, a novel glycosyhransferase (GT) gene AbGT5 from Aloe barbadensis was successfully cloned, heteroge- neously expressed and purified. Recombinant AbGT5 was able to catalyze the glycosylation of DMEP and the glycosylated product, which was separated from the preparative scale reaction, was characterized as DMEP 4'-O-β-D-glucoside via MS, I H-NMR, 13 C-NMR, HSQC and HMBC. According to the investigations of enzyme properties, AbGT5 show the highest activity around 20 ℃ in the buffer of pH 9. 0, and it was independent of divalent metal ions. Under the optimum conditions, the conversion rate of DMEP can reach 80%. Above all, in this work the enzymatic glycosylation of DMEP was achieved with high efficiency by the novel GT AbGTS.
出处 《中国中药杂志》 CAS CSCD 北大核心 2017年第12期2323-2328,共6页 China Journal of Chinese Materia Medica
基金 国家自然科学基金青年基金项目(81602999) 中国医学科学院医学与健康科技创新工程经费项目(CIFMS-2016-I2M-3-012 CIFMS-2016-I2M-2-002)
关键词 糖基转移酶 酶法糖基化 工具酶 4'-去甲基表鬼臼毒素 库拉索芦荟 glycosyltransferase enzymatic glycosylation tool enzyme 4'-demethylepipodophyllotoxin Aloe barbadensis
  • 相关文献

参考文献1

二级参考文献21

  • 1Giri A, Narasu M L. Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinical useful anticancer drugs. Cytotechnology, 2000, 34 (1/2):17-26.
  • 2Imbert T F. Discovery of podophyllotoxins. Biochimie, 1998,80 (3): 207-222.
  • 3Gordaliza M, Garcia P A, del Corral J M M, et al. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon, 2004, 44 (4): 441-459.
  • 4Wang L, MacDonald R C. Effects of microtubule-depolymerizing agents on the transfection of cultured vascular smooth muscle cells: enhanced expression with free drug and especially with drug-Gene lipoplexes. Mol Ther, 2004, 9 (5): 729-737.
  • 5Lee CTL, LinV C K, ZhangS X, etal. Anti-AIDS agents 29^1 anti-HIV activity of modified podophyllotoxin derivatives.Bioorg Med Chem Lett, 1997, 7 (22): 2897-2902.
  • 6Zhu X K, Guan J, Xiao Z Y, et al. Anti-AIDS agents Part 61 :Anti-HIV activity of new podophyllotoxin derivatives. Bioorg Med Chem, 2004, 12 (15): 4267-4273.
  • 7Eero S. Analgesic use of podophyllotoxin for treating pain conditions in female genital organs. US 6362222, 2002-03-26.
  • 8Canel C, Moraes R M, Dayan F E, et al. Molecules of interest podophyllotoxin. Phytochemistry, 2000, 54 (2): 115-120.
  • 9Gordaliza M, del Corral J M M, Castro M A, et al. Cytotoxic cyclo-lignans related to podophyllotoxin. Ⅱ Farmaco, 2001, 56(4) : 297-304.
  • 10Castro M A, del Corral J M M, Gordaliza M, et al. Synthesis and cytotoxicity of podophyllotoxin analogues modified in the A-ring. Eur J Med Chem, 2003, 38 (1): 65-74.

共引文献18

同被引文献28

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部